Comparison of the molecular responses and long-term outcomes with Nilotinib induction followed by Imatinib maintenance with Imatinib upfront in patients with chronic phase Chronic Myeloid Leukemia
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Imatinib (Primary) ; Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association